Bicyclic nitrogen-containing heterocyclic derivatives and pharmaceutical composition comprising the same

Provided are a novel compound having an antagonistic activity for the P2X7 receptor, and a pharmaceutical composition having an antagonistic activity for the P2X7 receptor. A compound represented by Formula (I):wherein Z1 is C(R4) or the like; R4 is a hydrogen atom or the like; Z2 is C(R5a)(R5a′) or...

Full description

Saved in:
Bibliographic Details
Main Authors Kai, Hiroyuki, Masuda, Koji, Ogawa, Tomoyuki, Kojima, Eiichi, Kobayashi, Naotake, Yamada, Toru, Sugiyama, Shuichi
Format Patent
LanguageEnglish
Published 27.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided are a novel compound having an antagonistic activity for the P2X7 receptor, and a pharmaceutical composition having an antagonistic activity for the P2X7 receptor. A compound represented by Formula (I):wherein Z1 is C(R4) or the like; R4 is a hydrogen atom or the like; Z2 is C(R5a)(R5a′) or the like; the dashed line represents the presence or absence of a bond; when the dashed line represents the presence of a bond, then R5a′ is absent; R5a and R5a′ are each independently a hydrogen atom or the like; Ring Q is a substituted or unsubstituted 5-membered non-aromatic heterocycle or the like; Y1 is O or the like; R2a is a group represented by the formula: -(C(R2a′)(R2b′))n-R1; R2b is a hydrogen atom or the like; R2a′ and R2b′ is each independently a hydrogen atom or the like; R1 is substituted or unsubstituted aromatic carbocyclyl or the like; X is N(R7a) or the like; R7a is a hydrogen atom or the like; R3 is substituted or unsubstituted aromatic carbocyclyl or the like; n is an integer from 0 to 4; and m is an integer from 0 to 4, or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: US202117349042